167 related articles for article (PubMed ID: 2706738)
1. Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation.
Lawrence HJ; Walsh D; Zapotowski KA; Denham A; Goodnight SH; Gandara DR
Cancer Chemother Pharmacol; 1989; 23(5):316-8. PubMed ID: 2706738
[TBL] [Abstract][Full Text] [Related]
2. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
Langer SW; Thougaard AV; Sehested M; Jensen PB
Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation.
Olver IN; Aisner J; Hament A; Buchanan L; Bishop JF; Kaplan RS
J Clin Oncol; 1988 Nov; 6(11):1732-5. PubMed ID: 3183703
[TBL] [Abstract][Full Text] [Related]
4. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
[TBL] [Abstract][Full Text] [Related]
5. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
[TBL] [Abstract][Full Text] [Related]
6. Toxicity to topical dimethyl sulfoxide in a pediatric patient with anthracycline extravasation.
Llinares ME; Bermúdez M; Fuster JL; Diaz MS; Gonzalez CM
Pediatr Hematol Oncol; 2005; 22(1):49-52. PubMed ID: 15770831
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole.
Ludwig CU; Stoll HR; Obrist R; Obrecht JP
Eur J Cancer Clin Oncol; 1987 Mar; 23(3):327-9. PubMed ID: 3595692
[TBL] [Abstract][Full Text] [Related]
8. Carnitine or dimethyl sulfoxide, or both, for the treatment of anthracycline extravasation in rats.
Uzunoglu S; Cosar R; Cicin I; Ibis K; Demiralay E; Benlier E; Erdogan B; Kandulu H; Ozen A; Altaner S
J Plast Surg Hand Surg; 2013 Oct; 47(5):339-43. PubMed ID: 23710793
[TBL] [Abstract][Full Text] [Related]
9. Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion.
Comas D; Mateu J
Ann Pharmacother; 1996 Mar; 30(3):244-6. PubMed ID: 8833558
[TBL] [Abstract][Full Text] [Related]
10. Management of anthracycline extravasation injuries.
Reeves D
Ann Pharmacother; 2007 Jul; 41(7):1238-42. PubMed ID: 17550954
[TBL] [Abstract][Full Text] [Related]
11. Managing skin damage induced by doxorubicin hydrochloride and daunorubicin hydrochloride.
Cox RF
Am J Hosp Pharm; 1984 Nov; 41(11):2410-4. PubMed ID: 6150636
[TBL] [Abstract][Full Text] [Related]
12. Extravasation accidents with liposomal/liposomal pegylated anthracyclines treated with dexrazoxane: an overview and outcomes.
Caballero Romero Á; Delgado Ureña MT; Salmerón García A; Megías Fernández MT; Librada Porriño-Bustamante M; Cabeza Barrera J
Anticancer Drugs; 2018 Oct; 29(9):821-826. PubMed ID: 30036190
[TBL] [Abstract][Full Text] [Related]
13. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
Tyson AM; Gay WE
Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757
[TBL] [Abstract][Full Text] [Related]
14. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases.
Cabriales S; Bresnahan J; Testa D; Espina BM; Scadden DT; Ross M; Gill PS
Oncol Nurs Forum; 1998; 25(1):67-70. PubMed ID: 9460774
[TBL] [Abstract][Full Text] [Related]
15. Case report: topical DMSO for mitomycin-C-induced skin ulceration.
Alberts DS; Dorr RT
Oncol Nurs Forum; 1991; 18(4):693-5. PubMed ID: 1906166
[TBL] [Abstract][Full Text] [Related]
16. Dimethyl sulfoxide for treating anthracycline extravasation.
Rospond RM; Engel LM
Clin Pharm; 1993 Aug; 12(8):560-1. PubMed ID: 8222519
[No Abstract] [Full Text] [Related]
17. Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents.
Casiraghi A; Ardovino P; Minghetti P; Botta C; Gattini A; Montanari L
Arch Dermatol Res; 2007 Jul; 299(4):201-7. PubMed ID: 17370081
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel extravasation.
Berghammer P; Pöhnl R; Baur M; Dittrich C
Support Care Cancer; 2001 Mar; 9(2):131-4. PubMed ID: 11305072
[TBL] [Abstract][Full Text] [Related]
19. Extravasation of pegylated-liposomal doxorubicin: favorable outcome after immediate subcutaneous administration of corticosteroids.
Mitsuma A; Sawaki M; Shibata T; Morita S; Inada M; Shimokata T; Sugishita M; Kitagawa K; Sawada M; Nawa A; Ando Y
Nagoya J Med Sci; 2012 Feb; 74(1-2):189-92. PubMed ID: 22515126
[TBL] [Abstract][Full Text] [Related]
20. DMSO and extravasation of mitomycin.
Herrera D; Burnham N
Oncol Nurs Forum; 1989; 16(2):155. PubMed ID: 2928263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
